![]() |
Name |
Drechmerin B
|
Molecular Formula | C28H37NO5 | |
IUPAC Name* |
(1S,2S,5S,7S,9R,10S,11R,14S)-9-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.02,11.05,10.016,24.017,22]tetracosa-16(24),17,19,21-tetraene-10-carboxylic acid
|
|
SMILES |
C[C@]12CC[C@H]3[C@]([C@@H]1CC[C@@H]4[C@@]2(C5=C(C4)C6=CC=CC=C6N5)C)([C@@H](C[C@H](O3)C(C)(C)O)O)C(=O)O
|
|
InChI |
InChI=1S/C28H37NO5/c1-25(2,33)22-14-20(30)28(24(31)32)19-10-9-15-13-17-16-7-5-6-8-18(16)29-23(17)27(15,4)26(19,3)12-11-21(28)34-22/h5-8,15,19-22,29-30,33H,9-14H2,1-4H3,(H,31,32)/t15-,19+,20+,21-,22-,26-,27+,28-/m0/s1
|
|
InChIKey |
BXGYSFFJFNFYKT-PEORYIHDSA-N
|
|
Synonyms |
Drechmerin B
|
|
CAS | NA | |
PubChem CID | 139590922 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 467.6 | ALogp: | 4.6 |
HBD: | 4 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 103.0 | Aromatic Rings: | 6 |
Heavy Atoms: | 34 | QED Weighted: | 0.51 |
Caco-2 Permeability: | -5.395 | MDCK Permeability: | 0.00001550 |
Pgp-inhibitor: | 0.093 | Pgp-substrate: | 0.975 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.009 |
Blood-Brain-Barrier Penetration (BBB): | 0.834 | Plasma Protein Binding (PPB): | 80.57% |
Volume Distribution (VD): | 0.462 | Fu: | 13.43% |
CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.734 |
CYP2C19-inhibitor: | 0.018 | CYP2C19-substrate: | 0.793 |
CYP2C9-inhibitor: | 0.177 | CYP2C9-substrate: | 0.413 |
CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.237 |
CYP3A4-inhibitor: | 0.306 | CYP3A4-substrate: | 0.496 |
Clearance (CL): | 4.627 | Half-life (T1/2): | 0.268 |
hERG Blockers: | 0.318 | Human Hepatotoxicity (H-HT): | 0.443 |
Drug-inuced Liver Injury (DILI): | 0.039 | AMES Toxicity: | 0.032 |
Rat Oral Acute Toxicity: | 0.927 | Maximum Recommended Daily Dose: | 0.919 |
Skin Sensitization: | 0.219 | Carcinogencity: | 0.623 |
Eye Corrosion: | 0.011 | Eye Irritation: | 0.018 |
Respiratory Toxicity: | 0.985 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004710 | ![]() |
0.812 | D0H4JM | ![]() |
0.341 | ||
ENC003932 | ![]() |
0.788 | D01JGV | ![]() |
0.290 | ||
ENC000857 | ![]() |
0.708 | D0U7GP | ![]() |
0.290 | ||
ENC002951 | ![]() |
0.613 | D0K0KH | ![]() |
0.260 | ||
ENC002707 | ![]() |
0.607 | D06CWH | ![]() |
0.253 | ||
ENC003172 | ![]() |
0.602 | D04RLY | ![]() |
0.253 | ||
ENC005406 | ![]() |
0.602 | D0T7ZQ | ![]() |
0.252 | ||
ENC005989 | ![]() |
0.602 | D06AEO | ![]() |
0.250 | ||
ENC005883 | ![]() |
0.598 | D0U3GL | ![]() |
0.250 | ||
ENC002279 | ![]() |
0.574 | D0Q6NZ | ![]() |
0.250 |